Abnormal expression of the NKG2D receptor has been observed in CD4+ T cells in patients with type 2 diabetes, particularly in a subset of CD4+CD28− T cells, which are more abundant compared to non-diabetic patients. The gene discussed is CD4; the disease is type 2 diabetes mellitus.